Articles tagged with West Nile Virus
A mathematical model helps determine necessary mosquito control levels to prevent West Nile virus outbreaks, reducing economic and environmental damage. The model takes into account regional factors such as mosquito life span and crow biology.
Purdue University biologists have determined the structure of the West Nile virus, a development that could greatly augment our understanding of the virus' life cycle. The research uses cryoelectron microscopy and advanced imaging techniques to understand how the major surface proteins interact with each other.
A live but weakened virus is being tested as a potential West Nile virus vaccine, with promising results showing high levels of protective antibodies in monkeys. The vaccine has been shown to be effective in preventing the disease-causing virus while triggering a strong immune response.
The Mayo Clinic Proceedings has released an early review of West Nile virus to aid clinicians and the public. The review, written by Priya Sampathkumar, M.D., provides the most current information on the disease's epidemiology, virology, transmission, management, and prevention in humans and animals.
A study of 23 West Nile patients reveals early symptoms include rash, low back pain, and limb pain, progressing to muscle weakness and respiratory failure in severe cases. The disease can cause significant disability and death if left untreated, emphasizing the importance of early diagnosis and treatment.
A new Web-based calculator will warn public health officials when and where mosquitoes carrying West Nile virus thrive or die, based on climate data. The system will help track mosquito populations' development and aging, which is crucial for predicting outbreaks.
Researchers found West Nile virus can cause muscle weakness, acute paralysis, and impaired breathing, leading to life-threatening symptoms. Four Mississippi patients who died after developing West Nile virus were examined and showed signs of viral infection in spinal cord autopsies.
Researchers analyzed 28 West Nile Virus cases, revealing that over half presented with neurological symptoms mimicking other diseases like stroke or Parkinson's. The study aims to increase awareness among neurologists and patients of the varied presentations of West Nile virus.
Researchers found that B cells and antibodies are essential for controlling the infection in mice. Without them, even low doses of the virus can be deadly. The study's findings may explain why elderly people and those with weakened immunity are more likely to develop serious disease.
Researchers at the University of Pennsylvania School found that the West Nile virus capsid protein can cause inflammation and apoptosis in cells, leading to encephalitic inflammation. The study suggests that blocking the protein's pathogenicity may help slow down the virus.
NASA's Public Health Applications Program aims to provide public health agencies with innovative technologies, data, and satellite-based tools to combat the disease. The program helps identify environmental indicators, predicts disease outbreaks, and informs mosquito surveillance efforts.
The ACP Annals Tip Sheet discusses growth hormone deficiency treatment, exercise counseling effectiveness, and West Nile virus prevention strategies. The USPSTF found mixed evidence on exercise counseling's impact on patient activity, while recommending public mosquito control programs for virus prevention.
A NASA-funded study utilizes satellite data on temperature and vegetation to forecast West Nile Virus transmission and identify high-risk areas. The analysis reveals that mosquito populations thrive in warmer, wetter conditions, allowing researchers to pinpoint disease hotspots and make predictions about future outbreaks.
Researchers have found that a Japanese encephalitis (JE) vaccine may also protect people from the most serious complication associated with West Nile virus infection. The study tested two vaccines in hamsters and found that they provided better protection than other options, including a yellow fever vaccine.
Yale scientists have successfully immunized mice against West Nile virus, providing a promising lead for developing a vaccine for humans. The vaccine was developed using a protein found in the virus and showed complete protection against the disease.
Researchers found that the New York City outbreak of West Nile virus in 1999 may have had up to 13,000 infections, including 1,700 febrile cases. Older adults and those without mosquito repellent were at higher risk for severe illness.
Two unique cases of West Nile virus infection reported in Neurology, showing deceptive symptoms initially misdiagnosed as Guillain-Barré Syndrome. Both patients eventually fully recovered, but highlight the need for greater awareness and testing for the mosquito-borne virus.